Value of Ki-67 in prediction of response to neoadjuvant chemotherapy in breast cancer

被引：0
|
作者：
Kim, Kwanil [1 ]
Lee, Kyunghee [1 ]
Park, Heungkyu [1 ]
机构：
[1] Gachon Univ Gil Hosp, Dept Surg, Inchon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12025
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] Pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: Focus on Ki-67 and molecular subtypes
    Rapoport, B. L.
    Barnard-Tidy, J.
    Van Eeden, R. I.
    Smit, T.
    Nayler, S.
    Benn, C.
    ANNALS OF ONCOLOGY, 2019, 30 : 37 - 37
  • [22] Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancer
    Zhang, Guojing
    Xie, Wanqing
    Liu, Zhaozhe
    Lin, Chao
    Piao, Ying
    Xu, Long
    Guo, Fang
    Xie, Xiaodong
    TUMORI JOURNAL, 2014, 100 (02): : 136 - 142
  • [23] Predictive Value of Ki-67 for Neoadjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
    Peng, X.
    Liu, H.
    Yin, Q.
    Lang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E387 - E387
  • [24] Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy
    Kim, Ji-Yeon
    Oh, Jung Min
    Lee, Se Kyung
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Park, Yeon Hee
    Ahn, Jin Seok
    Kim, Kyunga
    Im, Young-Hyuck
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Ki-67 as Predictive Biomarker for Systemic Chemotherapy in Breast Cancer
    Bhamre, R.
    Patil, A.
    Singhai, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S132 - S132
  • [26] KI67 AS A PREDICTOR OF CLINICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN TRIPLEPOSITIVE BREAST CANCER
    Ben Hamida, Karim
    Houcine, Yoldez
    Maaoui, Amal
    Hamza, Khedija
    Kamoun, Salma
    Ayadi, Senda
    Chargui, Riadh
    Driss, Maha
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A59 - A59
  • [27] Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy
    Montagna, E.
    Bagnardi, V.
    Viale, G.
    Rotmensz, N.
    Sporchia, A.
    Cancello, G.
    Balduzzi, A.
    Galimberti, V.
    Veronesi, P.
    Luini, A.
    Mastropasqua, M. G.
    Casadio, C.
    Sangalli, C.
    Goldhirsch, A.
    Colleoni, M.
    ANNALS OF ONCOLOGY, 2015, 26 (02) : 307 - 313
  • [28] Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy
    Montagna, Emilia
    Bagnardi, Vincenzo
    Viale, Giuseppe
    Rotmensz, Nicole
    Sporchia, Andrea
    Cancello, Giuseppe
    Balduzzi, Alessandra
    Galimberti, Viviana
    Veronesi, Paolo
    Luini, Alberto
    Mastropasqua, Mauro G.
    Casadio, Chiara
    Sangalli, Claudia
    Goldhirsch, Aron
    Colleoni, Marco
    CANCER RESEARCH, 2015, 75
  • [29] Correlation between FLT-PET and Ki-67 change in breast cancer during neoadjuvant chemotherapy
    Blackman, S. C.
    Railkar, R. A.
    Fox, R.
    George, L.
    Iannone, R.
    Bergstrom, D. A.
    Mozley, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
    Tao, Miaomiao
    Chen, Shu
    Zhang, Xianquan
    Zhou, Qi
    MEDICINE, 2017, 96 (51)
12345